Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rapamycin for Dermal Atrophy
NCT03103893Phase 2Completed
- Sponsor
- Drexel University
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sirolimus in dermal atrophy, sponsored by Drexel University. Primary endpoint: Dermal thickness. Started Sep 2017; status: completed.
02
Drugs
sirolimus
03
Conditions
dermal atrophy
Beyond the preview
Go deeper on NCT03103893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103893.